Log in
Enquire now
‌

Demonstrate Efficacy and Safety of Metastatic Breast Cancer

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT01084876
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT010848760
Health Conditions in Trial
Metastatic breast cancer
Metastatic breast cancer
0
Trial Recruitment Size
3830
Trial Sponsor
Celltrion
Celltrion
0
Clinical Trial Start Date
2010
0
Primary Completion Date
2011
0
Study Completion Date
2017
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
Herceptin0
CT-P60
Paclitaxel0
Interventional Trial Phase
Phase 30
Official Name
Double-blind, Randomised, Parallel Group, Phase III Study0
Last Updated
February 12, 2015
0
Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Triple0
Masked Party
Participant0
Investigator0
Care Provider0
Study summary

The purpose of the study is to to demonstrate equivalence

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Demonstrate Efficacy and Safety of Metastatic Breast Cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us